Modulation of cis-diamminedichloroplatinum (II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells

被引:38
作者
Marverti, G
Andrews, PA
Piccinini, G
Ghiaroni, S
Barbieri, D
Moruzzi, MS
机构
[1] SEZ CHIM BIOL,I-41100 MODENA,ITALY
[2] SEZ PATOL GEN,I-41100 MODENA,ITALY
[3] GEORGETOWN UNIV,DEPT PHARMACOL,WASHINGTON,DC 20007
关键词
cisplatin; drug resistance; drug transport; cell membrane permeability; polyamines;
D O I
10.1016/S0959-8049(96)00507-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of spermine (Sp), a natural polycationic amine, on cisplatin (CDDP) sensitivity and accumulation of a human ovarian CDDP-sensitive cell line (2008) and its resistant variant (C13*) was investigated. Survival was also studied. The C13* cells were approximately 20-fold resistant to CDDP, yet were found to be lust as sensitive to Sp as 2008 cells. When Sp was concurrently added with CDDP to the colony-forming assay, the IC50 dose was approximately 3-fold lower than that of CDDP alone. This decrease was the result of a synergistic interaction, as assessed by median effect analysis. The incubation of cells with the approximate IC50 dose of Sp for 1-8 h indicated that this synergism could be due to stimulation of CDDP accumulation, showing maximal uptake after 4 h of Sp exposure. This stimulation may be the result of a modulation of cellular membrane permeability by Sp, as assessed by the accumulation of [H-3]mannitol. Exposure to Sp concentrations active on CDDP uptake also significantly increased [H-3]mannitol accumulation in both cell lines. The triamine spermidine (Spd) did not significantly affect either the sensitivity of the two cell lines or CDDP and [H-3]mannitol accumulation. These results suggest that Sp is a positive modulator of CDDP uptake, and thus of its cytotoxicity, even in resistant cells, where the phenotype is partly due to a CDDP accumulation defect. (C) 1997 Published by Elsevier Science Ltd.
引用
收藏
页码:669 / 675
页数:7
相关论文
共 31 条
[1]  
ALLEN ED, 1986, CANCER RES, V46, P3550
[2]   INHIBITION OF LYMPHOCYTE-PROLIFERATION BY POLYAMINES REQUIRES RUMINANT-PLASMA POLYAMINE OXIDASE [J].
ALLEN, JC ;
SMITH, CJ ;
HUSSAIN, JI ;
THOMAS, JM ;
GAUGAS, JM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 102 (01) :153-158
[3]  
Andrews P. A., 1994, ANTICANCER DRUG RESI, P217
[4]  
ANDREWS PA, 1992, CANCER RES, V52, P1895
[5]   RAPID EMERGENCE OF ACQUIRED CIS-DIAMMINEDICHLOROPLATINUM(II) RESISTANCE IN AN INVIVO MODEL OF HUMAN OVARIAN-CARCINOMA [J].
ANDREWS, PA ;
JONES, JA ;
VARKI, NM ;
HOWELL, SB .
CANCER COMMUNICATIONS-US, 1990, 2 (02) :93-100
[6]  
ANDREWS PA, 1988, CANCER RES, V48, P68
[7]  
ANDREWS PA, 1991, CANCER RES, V51, P3677
[8]  
ANDREWS PA, 1987, PLATINUM OTHER METAL, P248
[9]   CYTOTOXIC EFFECT OF OXIDIZED SPERMINE ON EHRLICH ASCITES CELLS [J].
BACHRACH, U ;
ABZUG, S ;
BEKIERKUNST, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 134 (01) :174-+
[10]   TREATMENT WITH POLYAMINE SYNTHESIS INHIBITORS REDUCES THE POSITIVE INOTROPIC EFFECT OF OUABAIN, NORADRENALINE AND CALCIUM [J].
BAZZANI, C ;
GENEDANI, S ;
TAGLIAVINI, S ;
PICCININI, G ;
BERTOLINI, A .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1988, 20 (01) :23-35